drugset / Trial / NCT05607589
The Safety, Tolerability, PK, and PD of DWP213388 After SAD and MAD Administration in Healthy Adult Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Phase 1, First-in-human, Randomized, Double-blind, Placebo controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DWP213388 after Single and Multiple Ascending Oral Dose Administration in Healthy Adult Subjects
Timeline
- Start
- 2022-10
- Primary completion
- 2024-02-20
- Completion
- 2024-03-08
Outcome
Outcome not reported
Stopped: “Withdrawal of Clinical Trial due to Licensing Out”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DWP213388 | Unknown | — | Oral |
Indications
No indication recorded.